ACSBG1
Long-chain-fatty-acid--CoA ligase ACSBG1
Also known as: ACBG1_HUMAN, BG1, BGM, FLJ30320, hBG1, hsBG, KIAA0631, MGC14352
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96GR2
- Gene
- ACSBG1
- Ensembl
- ENSG00000103740
- Chromosome
- 15
- Canonical length
- 724 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
The protein encoded by this gene possesses long-chain acyl-CoA synthetase activity. It is thought to play a central role in brain very long-chain fatty acids metabolism and myelinogenesis. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
724 residues, UniProt reviewed canonical sequence.
>Q96GR2|ACSBG1
1 MPRNSGAGYG CPHGDPSMLD SRETPQESRQ DMIVRTTQEK LKTSSLTDRQ PLSKESLNHA
61 LELSVPEKVN NAQWDAPEEA LWTTRADGRV RLRIDPSCPQ LPYTVHRMFY EALDKYGDLI
121 ALGFKRQDKW EHISYSQYYL LARRAAKGFL KLGLKQAHSV AILGFNSPEW FFSAVGTVFA
181 GGIVTGIYTT SSPEACQYIA YDCCANVIMV DTQKQLEKIL KIWKQLPHLK AVVIYKEPPP
241 NKMANVYTME EFMELGNEVP EEALDAIIDT QQPNQCCVLV YTSGTTGNPK GVMLSQDNIT
301 WTARYGSQAG DIRPAEVQQE VVVSYLPLSH IAAQIYDLWT GIQWGAQVCF AEPDALKGSL
361 VNTLREVEPT SHMGVPRVWE KIMERIQEVA AQSGFIRRKM LLWAMSVTLE QNLTCPGSDL
421 KPFTTRLADY LVLAKVRQAL GFAKCQKNFY GAAPMMAETQ HFFLGLNIRL YAGYGLSETS
481 GPHFMSSPYN YRLYSSGKLV PGCRVKLVNQ DAEGIGEICL WGRTIFMGYL NMEDKTCEAI
541 DEEGWLHTGD AGRLDADGFL YITGRLKELI ITAGGENVPP VPIEEAVKME LPIISNAMLI
601 GDQRKFLSML LTLKCTLDPD TSDQTDNLTE QAMEFCQRVG SRATTVSEII EKKDEAVYQA
661 IEEGIRRVNM NAAARPYHIQ KWAILERDFS ISGGELGPTM KLKRLTVLEK YKGIIDSFYQ
721 EQKMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACSBG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 39 nTPM
- basal ganglia: 35 nTPM
- midbrain: 29 nTPM
- cerebral cortex: 26 nTPM
- amygdala: 23 nTPM
- hippocampal formation: 16 nTPM
Single-cell type
- astrocytes: 363 nCPM
- bergmann glia: 162 nCPM
- cardiomyocytes: 119 nCPM
- oocytes: 97 nCPM
- oligodendrocytes: 83 nCPM
- differentiating spermatogonia: 74 nCPM
Immune cell
- plasmacytoid DC: 1 nTPM
- total PBMC: 0.3 nTPM
- neutrophil: 0.2 nTPM
- basophil: 0.1 nTPM
- memory B-cell: 0.1 nTPM
- naive B-cell: 0.1 nTPM
Brain region
- white matter: 133 nTPM
- medulla oblongata: 115 nTPM
- spinal cord: 114 nTPM
- basal ganglia: 102 nTPM
- midbrain: 99 nTPM
- pons: 93 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.61
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.83
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- long-chain fatty acid biosynthetic process
- long-chain fatty acid metabolic process
- long-chain fatty-acyl-CoA biosynthetic process
- myelination
- response to glucocorticoid
- very long-chain fatty acid metabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- AMP-dependent synthetase/ligase domain
- AMP-binding, conserved site
- ANL, N-terminal domain
- AMP-binding enzyme
- AMP-binding enzyme C-terminal domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACSBG1 as an antibody target. Whether an autoantibody or antibody against ACSBG1 could matter depends on whether native ACSBG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACSBG1 is annotated at the cell surface, where native ACSBG1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ACSBG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...